Immunotherapy

1. What is Immunotherapy?

Immunotherapy uses medicines or other biological approaches to modify or strengthen the body's immune response against cancer. Some treatments help immune cells recognise cancer cells that may otherwise avoid immune detection.

2. When is it Recommended?

Immunotherapy may be recommended for selected patients with cancers such as melanoma, lung cancer, kidney cancer, bladder cancer, head and neck cancer, liver cancer and certain other cancers, depending on the cancer type, stage, previous treatment and relevant biomarkers.

3. What Does the Treatment Involve?

Before treatment, the oncologist reviews the patient's biopsy and pathology results, molecular or biomarker testing where appropriate, imaging studies, previous treatments and overall health.

Immunotherapy medicines are commonly administered through intravenous infusion at scheduled intervals, although the exact treatment protocol depends on the medicine and cancer type.

4. How Long Does Treatment Take?

The duration varies significantly. Treatment may continue for several months or longer, depending on the patient's response, cancer type, treatment protocol and side effects.

5. What Are the Main Types of Immunotherapy?

Depending on the cancer, immunotherapy may include:

• Immune checkpoint inhibitors
• Monoclonal antibodies
• CAR-T cell therapy for selected cancers
• Cancer vaccines in specific situations
• Other specialised immune-based treatments

The appropriate treatment depends on the patient's individual diagnosis.

6. What Are the Possible Benefits?

Some patients experience significant tumour reduction or prolonged disease control. However, response varies considerably, and immunotherapy is not effective or appropriate for every patient.

7. What Are the Important Risks or Side Effects?

Because immunotherapy activates or modifies the immune system, it can sometimes cause the immune system to affect healthy organs. Possible side effects may involve the:

• Skin
• Intestines
• Lungs
• Liver
• Kidneys
• Hormone-producing glands

Some immune-related side effects can become serious and require prompt medical treatment.

8. Why Consider Treatment in India?

India has specialised oncology centres offering medical oncology, molecular diagnostics, immunotherapy, advanced cancer imaging and multidisciplinary cancer care for appropriate patients.

9. How Can Medavelle Help?

Medavelle can assist with:

Medical-record review → Oncology specialist coordination → Hospital selection → Treatment planning → Cost estimation → International patient arrangements.

10. What Should the Patient Do Next?

Share biopsy & pathology reports → Oncology evaluation → Biomarker review → Treatment recommendation → Immunotherapy planning.